LATEST NEWS & PUBLICATIONS
U.S. Pharmaceutical Tariffs Expand to Generic Drugs
U.S. Pharmaceutical Tariffs Expand to Generic Drugs: What Manufacturers Need to Know When Prescription Analytics first examined pharmaceutical tariff policy in 2025, no pharma-specific framework had been finalized. Since then, the policy has advanced, with a branded...
CMS Confirms Q2 2026 ASP Reporting Requirements for Reasonable Assumptions and BFSF Documentation
CMS Confirms Q2 2026 ASP Reporting Requirements for Reasonable Assumptions and BFSF Documentation CMS has provided updated guidance on the new Average Sales Price (ASP) reporting requirements related to reasonable assumptions and, where applicable, bona fide service...
Are You Considering Lowering Your WAC?
ARE YOU CONSIDERING LOWERING YOUR WAC? What Pharma Manufacturers Need to Know Before Making the Move A WAC decrease can look simple on paper. For pharmaceutical manufacturers, lowering the Wholesale Acquisition Cost may seem like a straightforward pricing decision to...
OUR DIFFERENCE
Access
- Direct access to your analyst and company leadership
- Available 24/7 to support your needs
Accuracy
- Apply discipline to fully compliant SOPs
- All deliverables subject to strict layers of reviews and audits
Dependability
- Consistent ownership & business partners
- Vested in your long-term success
Transparency
- Clients own all data
- Full access to all scrubbed data, computations and processes
Problems Solved — Opportunities Leveraged.
Find out how we can support your critical analytic, processing and financial functions.